Clinical Trials in New York

Showing 19401-19420 of 22,668 trials

COMPLETEDPhase 1< 1 mile

A Study of of MORAb-004 in Subjects With Solid Tumors

NCT00847054

The purpose of this study is to determine the safety of multiple intravenous infusions of MORAb-004.

Solid Tumor

Morphotek80 participantsStarted Mar 2009

Baltimore, Maryland, United States • New York, New York, United States • Philadelphia, Pennsylvania, United States

TERMINATEDPhase 1< 1 mile

A Safety and MORAb-028 Dose Determination Study in Subjects With Metastatic Melanoma

NCT01212276

The purpose of this study is to evaluate whether therapy with MORAb-028 is safe, effective, and to determine the appropriate dose of MORAb-028 in the treatment of metastatic melanoma.

Metastatic MelanomaMalignant Metastatic MelanomaAdvanced Melanoma+1 more

Morphotek18 participantsStarted Dec 2010

New York, New York, United States

COMPLETED< 1 mile

Non-invasive Chromosomal Examination of Trisomy Study

NCT01511458

The purpose of this blinded, multi-center, prospective, case-controlled study is to compare the Ariosa Harmony™ Prenatal Test for trisomy 21 detection with a standard first-trimester prenatal screening test consisting of serum screening (PAPP-A,free beta-hCG \[β-hCG\] or total hCG) and a nuchal translucency (NT) measurement (i.e. combined first trimester screening) in a general screened population. The performance characteristics of these two test modalities will be assessed relative to the clinical reference standard of genetic analysis of the fetus or phenotypic characterization and genetic analysis of the newborn.

Trisomy 21

Roche Sequencing Solutions18,955 participantsStarted Mar 2012

Tucson, Arizona, United States • Oakland, California, United States • Palo Alto, California, United States +33 more locations

A Study of of MORAb-004 in Subjects With Solid Tumors

A Safety and MORAb-028 Dose Determination Study in Subjects With Metastatic Melanoma

Non-invasive Chromosomal Examination of Trisomy Study

Find Trials by Condition in New York

Change in Penile Length Following Bilateral Nerve-Sparing Radical Prostatectomy

Evaluating E7389 in Patients With Hormone Refractory Prostate Cancer With Advanced and/or Metastatic Disease Stratified by Prior Chemotherapy

ALD-101 Adjuvant Therapy of Unrelated Umbilical Cord Blood Transfusion (UCBT) in Patients With Inherited Metabolic Diseases

VX-222 + Telaprevir + Ribavirin for 12 or 16 Weeks in Treatment-Naive Subjects With Genotype 1a Hepatitis C

Comparing Anastrozole-Placebo to the Combination Anastrozole-ZD1839 in Postmenopausal Patients With Estrogen Receptor and/or Progesterone Receptor Metastatic Breast Cancer

Effectiveness of a Depression Care Management Initiative in Home Healthcare

A Study to Determine the Effect of Food on the Pharmacokinetics of PCI-32765

Study of GTx-024 on Muscle Wasting (Cachexia) Cancer.

Efficacy and Safety of CIP-Isotretinoin in Patients With Severe Recalcitrant Nodular Acne

An Open-label Study of GSK1120212 Compared With Docetaxel in Stage IV KRAS-mutant Non-small Cell Lung Cancer

Safety and Efficacy of INGAP-Peptide in Patients With Type 2 Diabetes

RAMP Study: A Study Comparing Two Lumbar Fusion Procedures

A Safety and Tolerability Study of Doripenem Compared With Meropenem in Children Hospitalized With Complicated Intra-abdominal Infections

Pediatric Bipolar Depression

A Safety and Tolerability Study of Doripenem Compared With Cefepime in Hospitalized Children With Bacterial Pneumonia

A Study to Evaluate the Safety and Efficacy of FK506E (MR4) in Patients Undergoing Primary Kidney Transplantation

Study of an Investigational Drug for the Prevention of Thrombosis-related Events Following Knee Replacement Surgery